GENA-25 Hemophilia A

Bleeding and Clotting Disorders

Protocol:GENA-25

Condition or Disease: Hemophilia A

Study Type: Observational

Status: Open for enrollment

Study Title: PRactical utilization of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment (with Nuwiq, Octanate or Wilate) ‰ÛÒ A Real- World Efficacy and Safety Observational Study

Principal I investigator: Joseph Lasky III, MD

More Info: //clinicaltrials.gov/ct2/show/NCT03695978

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Explore More News
Blog

Cure 4 The Kids Foundation Adds Dr. Suraj Pratap To Its Team of Exceptional Providers

Cure 4 The Kids Foundation (C4K) is pleased to announce the addition of Dr. Suraj Pratap, M.D. to their team of healthcare providers. Dr. Pratap brings with him a wealth of experience, having previously practiced general pediatrics in Las Vegas. He recently obtained his board-certification in pediatric hematology oncology, which will provide additional resources and expertise to C4K’s existing team of seven providers. Fluent in both English and Hindi, Dr. Pratap is now seeing C4K patients.

December 6, 2023
Cure 4 The Kids Foundation logo
Stay In Touch
Twitter Facebook-f Instagram Linkedin Youtube